EXECUTIVE INSIGHTS
DOMAIN EXPERTS
PLAYERS
PARTICIPANTS
-
MAR 2024
-
EDITION 21
-
TABLES 150
-
REGIONS 13
-
SEGMENTS 12
-
PAGES 486
-
US$ 5450
-
MCP-1506
-
JOIN OUR PANEL
EXECUTIVE ENGAGEMENTS BY TIER
-
CXO
-
VICE PRESIDENT
-
DIRECTOR
-
MANAGER
-
MARKETING
© Copy rights Global Industry Analysts, Inc., USA. www.strategyr.com All Rights Reserved.
OUR EXPERT PANELS
Panelists are carefully chosen based on their domain expertise and market influence.
Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.
WHY PARTICIPATE?
Expertise to the Power of YOU!
- Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
- Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
- Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
- Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
- Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription
- The Economist
- MIT Technology Review
- Harvard Business Review
Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.
MARKETGLASS
BASIC
- Annual Prepaid Subscription
- Single-User
- 10,000 Data Room Credits/Month
- Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
- Use MarketGlassTM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
- My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
PREMIUM
- Annual Prepaid Subscription
- One Research Project With One Complimentary Update/Year
- 10-User License
- 10-User Peer-to-Peer Collaborative Features
- 200 Domain Expert Insights (With Name, Company, and Date)
- 50,000 Data Room Credits
- Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
- Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
- Use Your Own Data and MarketGlassTM Data Room Content.
- My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
- Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges
ENTERPRISE
- Annual Prepaid Subscription
- Four Research Projects With One Complimentary Update/Year
- 25-User License
- 25-User Peer-to-Peer Collaborative Engagements
- 500 Domain Expert Insights (With Name, Company, and Date)
- 150,000 Data Room Credits
- Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
- Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
- Use Your Own Data and MarketGlassTM Data Room Content.
- My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
- Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges
HIGHLIGHTS & REPORT INDEX
Global Drug Discovery Technologies Market to Reach $110.9 Billion by 2030
The global market for Drug Discovery Technologies estimated at US$62.3 Billion in the year 2023, is expected to reach US$110.9 Billion by 2030, growing at a CAGR of 7.5% over the period 2023-2030. Small Molecule Drugs, one of the segments analyzed in the report, is expected to record 7.2% CAGR and reach US$82.4 Billion by the end of the analysis period. Growth in the Biologics segment is estimated at 8.2% CAGR for the next 8-year period.
The U.S. Market is Estimated at $18.7 Billion, While China is Forecast to Grow at 9.3% CAGR
The Drug Discovery Technologies market in the U.S. is estimated at US$18.7 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$19 Billion by the year 2030 trailing a CAGR of 9.3% over the analysis period 2023 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.8% and 6.3% respectively over the 2023-2030 period. Within Europe, Germany is forecast to grow at approximately 7.2% CAGR.
Introducing Our Exciting New Report Features for 2024
» Full access to influencer engagement stats
» Free access to our digital archives & "MarketGlass" research platform. Our proprietary MarketGlass platform is fully enabled to unlock creativity and market knowledge of domain experts worldwide in a cohesive and collaborative manner. Our state-of-art tools bring world class market perspectives while protecting participants` privacy and identity. Numbers, statistics and market narrative in the report are based on fully curated insights shared by domain experts and influencers in this space.
» Opportunity to engage with interactive questionnaires that come with real-time data simulator tools & bespoke report generation capabilities
» Full client access to peer collaborative and interactive platform for cross-enterprise smart exchange of ideas
» Complimentary report updates for one year
» Competitor coverage with global market shares of major players
» Player market presence analysis (Strong/Active/Niche/Trivial) across multiple geographies
» Access to curated YouTube video transcripts of domain experts/influencer interviews, podcasts, press statements and event keynotes
What to Expect from the Global Economy in 2024
Edgy geopolitics, and economic instability caused by monetary policy tightening and ensuing higher interest rates will create a tumultuous landscape for 2024. Several factors will continue to exert pressure on the path to recovery including hostilities in the Middle East and increasingly common climate disasters. Among the risks, several positives are also taking shape such as growing signs of disinflation and easing of anxiety over stubborn inflation, supply chain normalization and price moderation despite volatility in energy costs. Elections across several G21 jurisdictions, notably in India and the United States, will have potential ramifications for capital flows and investment strategies. While India emerges as a compelling destination in the global investment landscape, U.S, based tech firms will continue to dominate, fueled by a dynamic ecosystem of talent and capital. Tech opportunities in Silicon Valley and beyond remain attractive for investors seeking high-growth prospects supported largely by a resilient albeit slowing domestic economy and conducive regulatory environment. Europe will continue to battle tight monetary policy and recession risks with U.K. having the most challenging outlook and running the greatest risk of recession in 2024. China remains a wild card with hope for growth in the country underpinned by government spending and improvements in consumer spending. The volatile environment will offer both opportunities and challenges for investors and businesses alike. Embracing volatility as a catalyst for growth together with agility and strategic foresight in navigating investment decisions will remain important for survival.
SELECT PLAYERS
Agilent Technologies, Inc.; Beckman Coulter, Inc.; Bio-Rad Laboratories, Inc.; Alnylam Pharmaceuticals, Inc.; Antares Pharma, Inc.; Ambrx, Inc.; ActivX Biosciences, Inc.; Alembic Pharmaceuticals Limited; BioVision, Inc.; Acadia Pharmaceuticals, Inc.; Beactica Therapeutics AB; Atomwise, Inc.; BeiGene LTD.; ATXA Therapeutics; Bayer Pharmaceuticals
SEGMENTS
» Type (Small Molecule Drugs, Biologics) » Technology (High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology, Other Technologies) » End-Use (Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Other End-Uses)
GEOGRAPHIES
» World » USA » Canada » Japan » China » Europe » France » Germany » Italy » UK » Rest of Europe » Asia-Pacific » Rest of World
TABLE OF CONTENTS
I. METHODOLOGY |
II. EXECUTIVE SUMMARY |
1. MARKET OVERVIEW |
Influencer Market Insights |
World Market Trajectories |
Drug Discovery Technologies – Global Key Competitors Percentage Market Share in 2023 (E) |
Competitive Market Presence - Strong/Active/Niche/Trivial for 129 Players Worldwide in 2023 (E) |
A Prelude to Drug Discovery Technologies |
Global Market Analysis and Prospects |
Global Drug Discovery Technologies Market Set to Witness Rapid Growth |
Regional Market Analysis |
Market Analysis based on Application |
Market Analysis based on End-User |
Competition |
Recent Market Activity |
2. FOCUS ON SELECT PLAYERS |
3. MARKET TRENDS & DRIVERS |
Late-Stage Drug Failures Drives Demand for Drug Discovery Technolgies |
EXHIBIT 4: Factors Leading to Failure of Drugs in Phase III Clinical Trials: Percentage Breakdown of Number of Cases for Efficacy, Pharmacokinetics, Toxicity and Others |
Cell-based Assays Play a Critical Role in Drug Discovery |
Major Types of Cell-Based HTS Assays for Drug Screening |
High-Content Screening (HCS) - An Expanding Technology in Cell-Based Assays |
High Content Screening - Key Application Areas |
Technology Advances in Drug Discovery Processes |
Increased Demand of Biochips in Drug Discovery to Drive Market Growth |
Increased Demand for Personalized Medicine to Drive Drug Discovery Technologies Market |
EXHIBIT 3: Global Personalized Medicine Market: Revenues in US$ Million for the Years 2019, 2021, 2023 and 2025 |
Proteomics and Genomics Drive Opportunities for Drug Discovery Technologies |
Proteomics Profiling to Expedite Drug Discovery |
Other Applications of Proteomics in Drug Discovery |
New Proteomics Technique to Aid Drug Screening & Biomarker Discovery |
Proteomic Approaches Gain Prominence in Cancer Drug Discovery |
Proteomics Technologies Used in Cancer Drug Discovery and Development |
Role of Proteomics in Oncology Biomarker Discovery |
Bioinformatics Tools along with Proteomics Accelerate the Process of Pathway Prediction |
Using AI in Drug Discovery: The Latest Market Research |
High-throughput Screening (HTS) – A Key Drug Discovery Technology |
HTS: Making Use of a Smarter Approach to Hit Discovery |
Emerging Technologies in Drug Discovery and Development |
Targeted Drug Development and Discovery |
Significance of Advanced Clinical Sequencing for Drug Developers |
Metabolomics: An Emerging Trend in Drug Discovery |
Impact of ADME-Tox Screening on New Drug Discovery |
EXHIBIT 3: Phase-I Clinical Trial Failures Before and After the Advent of Preclinical ADME/Pharmacokinetics |
Pharma Industry Renews Focus on Cost Optimization |
China and India: Hot Spots for R&D Investment |
Omics Technology to Witness Rapid Growth |
Adoption of Omics-based Technologies |
Increasing Demand for 3D Cell Culture in Drug Discovery |
4. GLOBAL MARKET PERSPECTIVE |
World Recent Past, Current & Future Analysis for Drug Discovery Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Drug Discovery Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Drug Discovery Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Small Molecule Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Small Molecule Drugs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Small Molecule Drugs by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Biologics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Biologics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for High Throughput Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for High Throughput Screening by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for High Throughput Screening by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Biochips by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Biochips by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Bioinformatics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Bioinformatics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Bioinformatics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Pharmacogenomics & Pharmacogenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Pharmacogenomics & Pharmacogenetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Pharmacogenomics & Pharmacogenetics by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Nanotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Nanotechnology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Nanotechnology by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Research Institutes by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Pharmaceutical Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Pharmaceutical Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Biotechnology Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Biotechnology Companies by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030 |
World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Revenues for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030 |
World Drug Discovery Technologies Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030 |
III. MARKET ANALYSIS |
UNITED STATES |
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E) |
USA Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
USA Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
USA 16-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2014, 2024 & 2030 |
USA Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
USA Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
USA 16-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2014, 2024 & 2030 |
USA Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
USA Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
USA 16-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
CANADA |
Canada Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Canada Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Canada 16-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2014, 2024 & 2030 |
Canada Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Canada Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Canada 16-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2014, 2024 & 2030 |
Canada Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Canada Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Canada 16-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
JAPAN |
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E) |
Japan Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Japan Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Japan 16-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2014, 2024 & 2030 |
Japan Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Japan Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Japan 16-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2014, 2024 & 2030 |
Japan Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Japan Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Japan 16-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
CHINA |
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E) |
China Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
China Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
China 16-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2014, 2024 & 2030 |
China Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
China Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
China 16-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2014, 2024 & 2030 |
China Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
China Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
China 16-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
EUROPE |
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E) |
Europe Recent Past, Current & Future Analysis for Drug Discovery Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2023 through 2030 and % CAGR |
Europe Historic Review for Drug Discovery Technologies by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Europe 16-Year Perspective for Drug Discovery Technologies by Geographic Region - Percentage Breakdown of Value Revenues for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030 |
Europe Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Europe Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Europe 16-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2014, 2024 & 2030 |
Europe Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Europe Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Europe 16-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2014, 2024 & 2030 |
Europe Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Europe Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Europe 16-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
FRANCE |
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E) |
France Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
France Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
France 16-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2014, 2024 & 2030 |
France Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
France Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
France 16-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2014, 2024 & 2030 |
France Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
France Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
France 16-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
GERMANY |
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E) |
Germany Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Germany Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Germany 16-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2014, 2024 & 2030 |
Germany Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Germany Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Germany 16-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2014, 2024 & 2030 |
Germany Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Germany Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Germany 16-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
ITALY |
Italy Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Italy Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Italy 16-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2014, 2024 & 2030 |
Italy Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Italy Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Italy 16-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2014, 2024 & 2030 |
Italy Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Italy Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Italy 16-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
UNITED KINGDOM |
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E) |
UK Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
UK Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
UK 16-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2014, 2024 & 2030 |
UK Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
UK Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
UK 16-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2014, 2024 & 2030 |
UK Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
UK Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
UK 16-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
REST OF EUROPE |
Rest of Europe Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Europe Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Europe 16-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2014, 2024 & 2030 |
Rest of Europe Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Europe Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Europe 16-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2014, 2024 & 2030 |
Rest of Europe Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of Europe Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of Europe 16-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
ASIA-PACIFIC |
Drug Discovery Technologies Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E) |
Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Asia-Pacific Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Asia-Pacific 16-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2014, 2024 & 2030 |
Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Asia-Pacific Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Asia-Pacific 16-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2014, 2024 & 2030 |
Asia-Pacific Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Asia-Pacific Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Asia-Pacific 16-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
REST OF WORLD |
Rest of World Recent Past, Current & Future Analysis for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of World Historic Review for Drug Discovery Technologies by Type - Small Molecule Drugs and Biologics Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of World 16-Year Perspective for Drug Discovery Technologies by Type - Percentage Breakdown of Value Revenues for Small Molecule Drugs and Biologics for the Years 2014, 2024 & 2030 |
Rest of World Recent Past, Current & Future Analysis for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of World Historic Review for Drug Discovery Technologies by Technology - High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of World 16-Year Perspective for Drug Discovery Technologies by Technology - Percentage Breakdown of Value Revenues for High Throughput Screening, Biochips, Bioinformatics, Pharmacogenomics & Pharmacogenetics, Nanotechnology and Other Technologies for the Years 2014, 2024 & 2030 |
Rest of World Recent Past, Current & Future Analysis for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses - Independent Analysis of Annual Revenues in US$ Million for the Years 2023 through 2030 and % CAGR |
Rest of World Historic Review for Drug Discovery Technologies by End-Use - Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses Markets - Independent Analysis of Annual Revenues in US$ Million for Years 2014 through 2022 and % CAGR |
Rest of World 16-Year Perspective for Drug Discovery Technologies by End-Use - Percentage Breakdown of Value Revenues for Research Institutes, Pharmaceutical Companies, Biotechnology Companies and Other End-Uses for the Years 2014, 2024 & 2030 |
IV. COMPETITION |
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com
DIFFERENTIATORS
Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .
What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).
WHAT SETS US APART
FULL STACK DATA ACCESS
- Primary Research Cluster Data
- Influencer Engagement Stats
- Evidence of Primary Research
- List of Companies Engaged
- Hundreds of Pages of Research
- Peer Collaborative Interactions
- Enterprise Data Exchanges
- MarketGlassTM Platform Insider
- Geographic Pricing Dynamics
- Competitive Shares by Country
- Brand Curation & Insights
- Domain Expert Pool
Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.
Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.
Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.
Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.
Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.
Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.
Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.
Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.
No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.